Published by Becker’s Healthcare, October 1, 2026 | Author: Aspirion
Winning the Appeal Isn’t Enough: Every Denial Is Telling You Something
Most revenue cycle teams judge denials management by overturn rate and dollars recovered. Both are lagging indicators. They show what was won back, not why the denial happened or whether it will land again next quarter. A team can overturn nearly every claim it works and still re-solve the same denial, with the same diagnosis and the same payer, month after month.
The Volume Keeps Climbing
Kodiak Solutions’ March 2026 analysis found revenue leakage across more than 2,300 hospitals rose roughly 25% in 2025, to $48.4 billion. Rising clinical denials tied to medical necessity were part of the cause. A 2026 survey found 76% of revenue cycle leaders expect denial rates to keep increasing. Appealing harder won’t keep up with that trend.
Payer Problem or Documentation Problem?
Recurring clinical denials usually trace back to one of two causes, and each calls for a different response:
- Payer behavior: Clinical support is strong, but claims are denied or upheld anyway. The answer is to go back with the evidence.
- Provider-side process gaps: A detail is missing or a criterion is unmet before the claim reaches the payer. That is a signal for clinical documentation improvement (CDI) and utilization management (UM) teams, not a case to re-argue.
Read the Whole Population
Appeals are labor-intensive, so teams triage and write off the long tail of smaller denials. Analyzing denials as a population changes that. Grouped by payer, diagnosis, and facility, a pattern like sepsis downgraded across multiple payers shows up as one fixable issue instead of a hundred unrelated accounts. A facility view shows which sites consistently bill claims with weaker clinical support.
What Changes the Economics
AI lowers the cost of building each appeal, which expands what is worth pursuing. It also makes the patterns in the backlog visible. Aspirion’s ClinIQ platform is designed for this. Aspirion client data shows appeals filed 2.2x faster, closures 1.4x faster, and a 64% successful resolution rate on clinical denials.
Read the full article here.